Emily Man
CEO & Co-Founder
Venova Technologies
The startup has developed a long-term barrier device that provides a discreet and reversible contraception method for women and individuals capable of pregnancy. This device minimizes side effects while empowering users to manage their reproductive health effectively, contributing to better family planning outcomes.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$90KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Problem
Current highly effective and reversible birth control methods rely on hormones or copper, which can cause unwanted side effects, leading many women to discontinue their use. Existing options often fail to meet the diverse needs and preferences of individuals seeking to manage their reproductive health. This results in a significant percentage of pregnancies being unplanned.
Solution
Venova Technologies is developing a long-acting, hormone-free, and copper-free barrier device designed to provide a highly effective yet reversible method of contraception. The device is intended to be discreetly worn within the reproductive system, offering a "set-it-and-forget-it" experience without the need for regular maintenance. It aims to provide a low-to-no side effect profile, without altering natural menstrual cycles or causing spotting. Venova's solution is designed for insertion by trained medical professionals and is being developed with a future self-removable design to enhance user autonomy.
Target Audience
The primary target audience includes women and individuals capable of pregnancy who seek a highly effective, long-acting, hormone-free, and copper-free contraception method with minimal side effects.
Features
- Hormone-free design eliminates hormonal side effects.
- Copper-free composition avoids side effects associated with copper IUDs and copper toxicity.
- Long-acting efficacy intended to last for several years.
- Reversible mechanism allows for immediate return to normal fertility upon removal.
- Discreet placement within the reproductive system for a "forgettable" user experience.
- Fitted to user, designed for insertion by trained medical professionals.
- Designed to be a low-cost and accessible option, even for patients without health insurance.
- Future self-removable design to give people more autonomy over their birth control.
- Demonstrated complete blockage of human sperm in in-vitro studies.
- Performance tested with hyper-realistic anatomical models and simulated fluids.